Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03881579 · ClinicalTrials.gov registry record · NA

Supportive Care for Cognitively Impaired Patients and Families

A NA study of Mild Cognitive Impairment and Dementia, sponsored by Stanford University.

Active
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT03881579: Active NA study of Mild Cognitive Impairment and Dementia, sponsored by Stanford University.

NCT03881579 is a NA study of Mild Cognitive Impairment and Dementia that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 200 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03881579, a NA study of Mild Cognitive Impairment and Dementia, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

Currently almost 5 million Americans suffer from the distressing symptoms related to dementia and this number that will triple by 2050. The overall goals of the proposed project are to evaluate, in community dwelling Alzheimer's Disease Research Center participants the benefits of a 12-month nurse-led early palliative intervention on symptoms, quality of life, health care resource use. The relevance of this research to public health is that there is an urgent need to improve the palliative care of persons with dementia living in the community. This study will contribute substantially to that effort.

Primary Outcome

Only the participants randomized to the intervention arm will receive the nurse-led supportive care intervention (one session per month over a twelve-month period). We hypothesize that compared to the control arm, many more patients in the intervention arm will express supportive needs and have them fulfilled by the study nurses.

Interventions

  • BEHAVIORAL nurse-led supportive care assessment

Study Locations (1)

California

  • VJ Periyakoil - Palo Alto

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-12-18
Est. Completion 2026-12-31
Phase NA
Stanford University

1,744 total trials

What the registry record for NCT03881579 still lists

NCT03881579 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (84% lower).

The record links to 3 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 1 intervention - of which nurse-led supportive care assessment is the first listed.

NCT03881579 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03881579 about?

NCT03881579 is a clinical study titled "Supportive Care for Cognitively Impaired Patients and Families". Currently almost 5 million Americans suffer from the distressing symptoms related to dementia and this number that will triple by 2050. The overall goals of the proposed project are to evaluate, in community dwelling Alzheimer's Disease Research Center participants the benefits of a 12-month nurse-l...

What is the current status of trial NCT03881579?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2019-12-18. Estimated completion is 2026-12-31.

What conditions does trial NCT03881579 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment, Dementia, Primary Palliative Care.

What interventions are being tested in trial NCT03881579?

The interventions under investigation include: nurse-led supportive care assessment (BEHAVIORAL).

Who is sponsoring clinical trial NCT03881579?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03881579 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03881579's enrollment target sits among peer trials

200 46th of 205 higher than 155 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03881579, the US trial registry maintained by the National Library of Medicine. NCT03881579 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.